CoChat

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Background There is conclusive evidence from clinical trials that reduction of mortality by fibrinolytic therapy in acute myocardial infarction is related to the time elapsing between onset of symptoms and commencement of treatment. However, the exact pattern of this relation continues to be debated. This paper discusses whether or not appreciable additional gain can be achieved with very early treatment.Methods The relation between treatment delay and short-term mortality (up to 35 days) was evaluated using tabulated data from all randomised trials of at least 100 patients (n = 22; 50,246 patients) that compared fibrinolytic therapy with placebo or control, reported between 1983 and 1993.Findings Benefit of fibrinolytic therapy was 65 (SD 14), 37 (9), 26 (6) and 29 (5) lives saved per 1000 treated patients in the 0-1, 1-2, 2-3, and 3-6 h intervals, respectively. Proportional mortality reduction was significantly higher in patients treated within 2 h compared to those treated later (44% [95% CI 32, 53] vs 20% [15, 25]; p = 0.001). The relation between treatment delay and mortality reduction per 1000 treated patients was expressed significantly better by a non-linear (19.4-0.6x(+)29.3x-1) than a linear (34.7 - 1.6x) regression equation (p = 0.03).Interpretation The beneficial effect of fibrinolytic therapy is substantially higher in patients presenting within 2 h after symptom onset compared to those presenting later.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(96)02514-7

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 3

  1. Fath-Ordoubadi, 1994, Meta-analysis of randomised trials of prehospital versus hospital thrombolysis, Circulation, 90, I-325
  2. 1988, Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial, Lancet, i, 545
  3. 1988, Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 h after onset of myocardial infarction, Lancet, i, 203

Cited by

See all 1,299

Metadata

Authors
Boersma, E., Maas, A. C., Deckers, J. W., & Simoons, M. L.
Affiliations
Erasmus University Rotterdam (NL)
Corresponding author
Simoons, Maarten L
Venue
The Lancet
Publisher
Elsevier BV
Published
1996-09
Volume
348
Issue
9030
Pages
771-775
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2129805832
Cited by
1,299
References
55
Citations by year
2026: 11 · 2025: 21 · 2024: 18 · 2023: 28 · 2022: 28 · 2021: 29 · 2020: 29 · 2019: 42 · 2018: 34 · 2017: 35 · 2016: 44 · 2015: 37 · 2014: 53 · 2013: 50 · 2012: 54
FWCI
8.61
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords
acute myocardial infarction, thrombolysis, golden hour, treatment delay, time to treatment, short-term mortality, mortality reduction, nonlinear dose-response relationship, randomised trials
MeSH terms
Animals, Fibrinolytic Agents, Humans, Myocardial Infarction, Time Factors, Thrombolytic Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. https://app.cochat.ai/papers/10.1016/s0140-6736(96)02514-7
The paper
Boersma, E., Maas, A. C., Deckers, J. W., & Simoons, M. L. (1996). Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. The Lancet. https://doi.org/10.1016/s0140-6736(96)02514-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.